Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contribution of Virtual Reality Eye Tracking in the Identification of Schizophrenia, Bipolar and Depression

NCT07057024 is registered in ClinicalTrials.gov with Etablissement Public de Santé Barthélemy Durand as lead sponsor.

NCT NCT07057024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07057024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contribution of Virtual Reality Eye Tracking in the Identification of Schizophrenia, Bipolar and Depression
Lead sponsor
Etablissement Public de Santé Barthélemy Durand
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 12, 2026
Completion date
February 28, 2029
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psychiatric disorders (diagnosis)